| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Accenture PLC | 20 | Q1 2018 | 2.1% |
| JP Morgan Chase & Co | 20 | Q1 2018 | 2.1% |
| Johnson & Johnson | 20 | Q1 2018 | 1.7% |
| Visa | 20 | Q1 2018 | 2.1% |
| Nestle Adr | 20 | Q1 2018 | 1.6% |
| Abbott Laboratories | 20 | Q1 2018 | 2.0% |
| Philip Morris Intl Inc | 20 | Q1 2018 | 1.7% |
| Oracle Corporation | 20 | Q1 2018 | 1.5% |
| Nike, Inc. Class B | 20 | Q1 2018 | 1.5% |
| Wells Fargo & Company | 20 | Q1 2018 | 1.4% |
View GENESEE VALLEY TRUST CO's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-04-03 |
| 13F-HR | 2018-02-06 |
| 13F-HR | 2017-10-06 |
| 13F-HR | 2017-08-07 |
| 13F-HR | 2017-05-02 |
| 13F-HR | 2017-02-22 |
| 13F-HR | 2016-10-12 |
| 13F-HR | 2016-07-26 |
| 13F-HR | 2016-05-11 |
| 13F-HR | 2016-02-11 |
View GENESEE VALLEY TRUST CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.